Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | 64 159 | déclaré | 04 mars 2026 | tx 164+215 561−40 284 |
| Q32 Bio Inc. | 23 000 | déclaré | 14 juin 2023 | tx 4+95 000 |
| CervoMed Inc. | 8 150 | déclaré | 08 juin 2026 | tx 4+28 450 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 08 juin 2026 | GRANT_AWARD | CervoMed Inc. | 8 150 | 0.00 USD | deriv |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 114 | 319.03 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 109 | 320.01 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 223 | 325.67 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 818 | 323.84 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 291 | 324.88 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 230 | 320.81 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 309 | 321.82 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 374 | 323.01 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 138 | 328.71 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 234 | 329.71 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 112 | 330.85 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 129 | 331.93 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 53 | 332.64 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 541 | 326.81 USD | |
| 02 mars 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 4 769 | 0.00 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 65 | 323.62 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 124 | 324.65 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 356 | 325.63 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 454 | 327.67 USD | |
| 02 mars 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 10 480 | 0.00 USD | deriv |
| 27 févr. 2026 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 1 908 | 0.00 USD | |
| 27 févr. 2026 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 1 908 | 0.00 USD | deriv |
| 12 févr. 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 4 579 | 0.00 USD | |
| 13 févr. 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 2 242 | 310.08 USD |